Pure Global

DIBUCAINE CHOLINESTERASE - ANVISA Registration 80146502233

Access comprehensive regulatory information for DIBUCAINE CHOLINESTERASE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502233 and manufactured by SENTINEL CH. SPA. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 2 companies making the same product including SENTINEL CH.SPA, ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
2 Recent Registrations
80146502233
Registration Details
ANVISA Registration Number: 80146502233
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Alinity c Dibucaine CHE Reagent Kit
Risk Class II

Registration Details

80146502233

25351454939201950

56998701000116

Company Information

SENTINEL CH. SPA
Italy
PT: ITรLIA

Dates and Status

Nov 18, 2019

VIGENTE

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "DIBUCAINE CHOLINESTERASE"